Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system

John S Brownstein1, Ken P Kleinman, Kenneth D Mandl

  • 1Division of Emergency Medicine, Children's Hospital Boston, Harvard Medical School, Boston, MA 02215, USA. john_brownstein@harvard.edu

Insights

Young children, especially preschoolers aged 3-4, are earliest to contract influenza and most strongly linked to mortality. Vaccinating this age group may reduce disease spread and deaths.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Disease

Background:

  • Influenza transmission among schoolchildren is a significant public health concern.
  • Current influenza vaccination strategies primarily target young children (6-23 months).

Purpose of the Study:

  • To identify pediatric age groups that experience the earliest influenza onset.
  • To determine which pediatric age groups are most strongly associated with influenza and pneumonia mortality.

Main Methods:

  • Utilized real-time syndromic surveillance data from six Massachusetts healthcare settings (2000-2004).
  • Analyzed patient visits for respiratory illness, segmented by age group.
  • Employed time-series analyses and regression models to assess timeliness and mortality prediction.

Main Results:

  • Patient age significantly impacted influenza timeliness, with pediatric groups presenting earliest (p < 0.001).
  • Children aged 3-4 years consistently showed the earliest onset (p = 0.0058).
  • Illness in children under 5 years was most strongly associated with mortality (p < 0.001).

Conclusions:

  • Findings support expanding influenza vaccination beyond the current 6-23 month age recommendation.
  • Vaccinating preschool-aged children (3-4 years) may be a valuable strategy to mitigate influenza transmission and mortality.